BR9814127A - New oral dosage form for carvedilol - Google Patents

New oral dosage form for carvedilol

Info

Publication number
BR9814127A
BR9814127A BR9814127-9A BR9814127A BR9814127A BR 9814127 A BR9814127 A BR 9814127A BR 9814127 A BR9814127 A BR 9814127A BR 9814127 A BR9814127 A BR 9814127A
Authority
BR
Brazil
Prior art keywords
carvedilol
dosage form
oral dosage
new oral
new
Prior art date
Application number
BR9814127-9A
Other languages
Portuguese (pt)
Inventor
Choon K Oh
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of BR9814127A publication Critical patent/BR9814127A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Abstract

"NOVA FORMA DE DOSAGEM ORAL PARA CARVEDILOL" A presente invenção revela uma formulação de matriz contendo carvedilol."NEW ORAL DOSAGE FORM FOR CARVEDILOL" The present invention discloses a matrix formulation containing carvedilol.

BR9814127-9A 1997-11-12 1998-11-12 New oral dosage form for carvedilol BR9814127A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6545697P 1997-11-12 1997-11-12
PCT/US1998/024102 WO1999024017A1 (en) 1997-11-12 1998-11-12 Novel oral dosage form for carvedilol

Publications (1)

Publication Number Publication Date
BR9814127A true BR9814127A (en) 2000-10-03

Family

ID=22062830

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814127-9A BR9814127A (en) 1997-11-12 1998-11-12 New oral dosage form for carvedilol

Country Status (14)

Country Link
EP (1) EP1030651A4 (en)
JP (1) JP2001522794A (en)
KR (1) KR20010031952A (en)
CN (1) CN1285738A (en)
AU (1) AU751117B2 (en)
BR (1) BR9814127A (en)
CA (1) CA2309542A1 (en)
HU (1) HUP0004345A3 (en)
IL (1) IL136028A0 (en)
NO (1) NO20002439L (en)
NZ (1) NZ504418A (en)
PL (1) PL340456A1 (en)
TR (1) TR200001362T2 (en)
WO (1) WO1999024017A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1562552A1 (en) 2002-11-08 2005-08-17 Egalet A/S Controlled release carvedilol compositions
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
JP2007512350A (en) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド Carvedilol composition treatment and delivery methods
EP1691789B1 (en) 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi Drug delivery composition
TWI415604B (en) * 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd Controlled release carvediolol formulation
EP2540294B1 (en) * 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
TW201132646A (en) * 2010-02-22 2011-10-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
TW201141544A (en) * 2010-02-22 2011-12-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
KR102127625B1 (en) 2012-09-03 2020-06-29 다이이찌 산쿄 가부시키가이샤 Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
KR102158339B1 (en) * 2016-02-05 2020-09-21 삼진제약주식회사 Carvedilol immediate release formulation having improved madescent
KR102492147B1 (en) 2020-12-30 2023-01-26 단국대학교 천안캠퍼스 산학협력단 Carvedilol loaded solid oral compositions using self-nanoemulsifying drug delivery system and methods for their preparation
KR102525298B1 (en) 2020-12-30 2023-04-25 단국대학교 천안캠퍼스 산학협력단 Carvedilol loaded solid dispersion with increased oral bioavailability and methods for their preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (en) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DK0554306T3 (en) * 1990-10-23 1996-03-18 Davband Pty Ltd Backrest for a chair or seat
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
DE19637082A1 (en) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Rapidly disintegrating pellets

Also Published As

Publication number Publication date
HUP0004345A3 (en) 2001-10-29
NO20002439D0 (en) 2000-05-11
TR200001362T2 (en) 2000-09-21
EP1030651A4 (en) 2006-05-31
NO20002439L (en) 2000-05-11
NZ504418A (en) 2003-02-28
JP2001522794A (en) 2001-11-20
CA2309542A1 (en) 1999-05-20
WO1999024017A1 (en) 1999-05-20
EP1030651A1 (en) 2000-08-30
IL136028A0 (en) 2001-05-20
AU751117B2 (en) 2002-08-08
AU1456999A (en) 1999-05-31
PL340456A1 (en) 2001-02-12
CN1285738A (en) 2001-02-28
KR20010031952A (en) 2001-04-16
HUP0004345A2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
HK1034455A1 (en) Oral pharmaceutical extended release dosage form.
DK0936913T3 (en) Oral pharmaceutical composition containing ibandronate
DE69833464D1 (en) A pharmaceutical composition containing 2,3-diaryl-pyrazolo1,5-bPyridazine derivatives
ZA963310B (en) Volatile substance dispenser with dissipation indication
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
ATE284695T1 (en) ORAL MEDICINAL COMPOSITION CONTAINING 2-METHYL-THIENOBENZODIAZEPINE
SE9704546D0 (en) Novel compounds
ES2161882T3 (en) ORAL METOPROLOL DOSAGE FORM, ONCE A DAY.
SE9704545D0 (en) Novel compounds
HK1020675A1 (en) Oil patches for external use containing diclofenac sodium
DK0956854T3 (en) Pharmaceutical composition containing coenzyme Q10
PT797991E (en) FORMULATION WITH PROLONGED LIBERATION CONTAINING VENLAFAXIN
BR9814127A (en) New oral dosage form for carvedilol
PL335502A1 (en) Paracetamol containing oral tablet
DK1023035T3 (en) The oral composition
NO20012930D0 (en) Azatioprine compositions for colon administration
PT868911E (en) RAPAMICINE FORMULATIONS FOR ORAL ADMINISTRATION
SE9802937D0 (en) Novel compounds
ES2177024T3 (en) EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
BG101401A (en) Cisaspide extended release oral compositions
DE59801987D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PEPTICHEMIO
EE9800400A (en) Pharmaceutical compositions containing diclofenac
GB9907571D0 (en) Compounds
DE69510545T2 (en) CCK OR GASTRINE MODULATING 5-HETEROCYCLICYL-1,5-BENZODIAZEPINE
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1971 DE 14/10/2008.